BlueBox Precision Medicine Fund A
LU2519372499
BlueBox Precision Medicine Fund A/ LU2519372499 /
NAV12/06/2024 |
Chg.+4.1899 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
1,130.2300USD |
+0.37% |
reinvestment |
Equity
Worldwide
|
Fuchs Asset M. ▶ |
Stratégie d'investissement
The main objective of the Fund is to seek to maximise total return.
The Fund invests globally with at least 85% of its total assets in the equity securities of companies whose predominant economic activity is in the pharmaceuticals, biotechnology and life science sectors. The overall investment strategy of the BlueBox Precision Medicine Fund is to seek out companies that will create value for the Shareholders from precision medicine: the multi-year trend of increasingly precise and targeted drug development in the pharmaceutical and biotechnology industries. The BlueBox Precision Medicine Fund will typically hold 25 to 45 positions. The holding periods are expected to be generally long (multiple years) and turnover low, although at times the BlueBox Precision Medicine Fund may utilise shorter holding periods if value is realised more quickly or unexpected events occur.
Objectif d'investissement
The main objective of the Fund is to seek to maximise total return.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Health / Pharma |
Benchmark: |
- |
Début de l'exercice: |
01/01 |
Dernière distribution: |
- |
Banque dépositaire: |
Northern Trust Global Services SE |
Domicile: |
Luxembourg |
Permission de distribution: |
Germany, Switzerland |
Gestionnaire du fonds: |
Mark Dainty |
Actif net: |
15.86 Mio.
USD
|
Date de lancement: |
14/06/2023 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
1.50% |
Investissement minimum: |
10,000.00 USD |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
- |
Société de fonds
Société de fonds: |
Fuchs Asset M. |
Adresse: |
49,boulevard Prince Henri, 1724, Luxembourg |
Pays: |
Luxembourg |
Internet: |
info@fuchsgroup.com
|
Actifs
Stocks |
|
98.20% |
Cash and Other Assets |
|
1.80% |
Pays
United States of America |
|
72.40% |
United Kingdom |
|
6.00% |
Belgium |
|
5.90% |
France |
|
5.30% |
Switzerland |
|
3.10% |
Italy |
|
3.00% |
Denmark |
|
2.50% |
Autres |
|
1.80% |
Branches
Pharma/Biotechnology |
|
64.90% |
Pharma, production |
|
3.00% |
Cash / other assets |
|
1.80% |
Autres |
|
30.30% |